Question to the Department of Health and Social Care:

To ask Her Majesty's Government what data outcomes are being collected by the COVID-19 Medicines Delivery Unit following the administration of (1) anti-virals, and (2) Sotrovimab, to COVID-positive patients; and when this data will be published.

NHS England and NHS Improvement collect information from COVID Medicine Delivery Units (CMDUs) on COVID-19 treatments prescribed and administered. This data includes the number of eligible non-hospitalised patients receiving an antiviral or neutralising monoclonal antibody treatment through a CMDU and the number of eligible hospitalised patients treated with an antiviral, neutralising monoclonal antibody, interleukin-6 inhibitor or JAK inhibitor. This information is published on weekly basis in an online only format and excludes treatments administered as part of clinical trials, such as the PANORAMIC or RECOVERY studies.

In addition, a number of independent studies are analysing data on outcomes for treated and untreated patients. While NHS England and NHS Improvement continue to work with the research community to understand this observational data and understand the impact of treatments on outcomes, these studies are conducted independently of the NHS and therefore information on potential publication dates is not held.